First of all, the ingredients of breakfast milk and pure milk are not the same. Pure milk has only three words on the list of ingredients: fresh milk. The ingredients of breakfast milk are more complicated—milk, water, sugar, malt, peanuts, egg powder, oats, etc., as well as stabilizers, iron fortifiers, zinc fortifiers, and flavors.
Look at their nutritional content, there are subtle differences. The protein content of pure milk is 2.9% to 3.1%, "fine" can reach 3. 3% to 3.5%, and breakfast milk is 2.3% or more. Obviously, after adding sugar, the protein content decreased slightly. However, because eggs, wheat, peanuts and other ingredients also contain a certain amount of protein, the overall reduction is not much.
Pure milk is a very nutritious food, but it is not perfect. On the other hand, if it is used as a staple food, the proportion of carbohydrates is a little lower, and it is better to use some low-fat starchy foods. At the same time, the natural defect of milk is that the content of iron and zinc is too low, and vitamin C is too little. So it is suitable for a little nut food, plus a little fruit or vegetables. A cup of milk, 2 slices of bread, 1 small nut, 1 kiwi fruit are just perfect breakfast.
If the breakfast time is quite abundant, drinking milk can be used with these foods, of course, is an ideal practice; but if time is tight, there is no way to eat breakfast? At that time, just drinking a box of milk is indeed much better than not drinking, but the nutritional balance It is not ideal enough. If you change to drinking milk for breakfast, compared to nutritional content more in line with the requirements of a meal.
Palbociclib is a drug for the treatment of ER-positive and HER2-negative breast cancer developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
It was reviewed and approved under the Food and Drug Administration`s (FDA) accelerated Priority Review and Breakthrough Therapy designation programs on February 3, 2015 as a treatment (in combination with letrozole) for patients with estrogen receptor positive advanced breast cancer.
We produce a series of complete intermediates for Palbociclib, intermediate I (CAS No. 571188-59-5), intermediate II (CAS No. 1013916-37-4) and intermediate III (CAS No. 1016636-76-2) etc.
All of our products are with stable production and strict quality control, making sure your experience with Sunshine Biotech is always enriching, satisfying and fulfilling.
Palbociclib Intermediates,Cas 571188-59-5,Cas 1013916-37-4,Cas 1016636-76-2
Nanjing Sunshine Biotech Co., Ltd , https://www.sunshine-bio.com